Page results
-
Using Attend Anywhere for video clinics You and your clinician are able to communicate over a secure online video system called Attend Anywhere. What do I need to make an Attend Anywhere video…
-
This page explains how to start using a breast pump.
-
Find out answers to the travel clinic services most commonly asked questions.
-
A new specialist blood transfusion service at Luton and Dunstable University Hospital is transforming care for people living with sickle cell disease (SCD) across the East of England.
-
UCLH cancer services including radiotherapy has been awarded the PIF TICK – the UK’s only assessed quality mark for print and online health and care information.
-
There are now seven patients participating in the GB-PRIME study involving Neuralink’s brain-computer interface (BCI) technology, which aims to improve independence for people who are paralysed.
-
Here you will find more information on our publications.
-
Medtronic have informed us that there is a potential issue relating to the battery cap on some Medtronic insulin pumps (including 640, 670 and 780 series pumps).
-
Adding the hormone therapy abiraterone to the standard treatment for locally advanced prostate cancer, where the cancer has a high chance of spreading, could halve the risk of death, according to the results of a trial at UCLH and UCL.
-
This page is for parents, carers and relatives whose child is having radiotherapy treatment to the eye (orbit). There are different conditions that may require radiotherapy to the eye such as retinoblastoma, orbital rhabdomyosarcomas, soft tissue sarcomas, lymphomas, or some other condition.
File results
-
FOI2017266 Viscosupplementation injections
-
FOI2017263 Self-administration of medicines policies and carers policies
-
FOI2017295 A&E attendances for acopia
-
FOI2017296 Contracts for the redevelopment of the Middlesex annexe and Royal London Hospital for Integrated Medicine
-
FOI2017307 Televisions for patients
-
FOI2017314 Deep brain stimulation procedures
-
FOI2017300 Sustainability and transformation
-
FOI2017315 Expenditure on reconciliation and validation of incomplete and missing RTT codes
-
FOI2017320 Patients with Multiple Sclerosis treated with MS disease modifying drugs
-
FOI/2023/0226 - Treatment with Nivolumab